Talapbek Azhenov

Dr. Talapbek Azhenov


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2024 in Medicina
Verified
Journal Article
Open access
PDF file
KSKalamkas Sagandykova
Kalamkas Sagandykova
NPNataliya Papulova
Nataliya Papulova
TATalapbek Azhenov
Talapbek Azhenov
ADAliya Darbekova
Aliya Darbekova
BABayan Aigozhina
Bayan Aigozhina
Jerome R. LechienJerome R. Lechien
Jerome R. Lechien
Chronic rhinosinusitis (CRS) is a complex inflammatory condition affecting the nasal and paranasal sinus mucosa. Gastroesophageal reflux disease (GERD) has been implicated as a potential exacerbating factor in CRS, but the specific endoscopic features of nasopharyngeal pathology in this context remain poorly understood. Background and Objectives: Chronic rhinosinusitis is a multifactorial disease with various underlying etiologies, including inflammation, anatomical factors, and environmental triggers. While gastroesophageal reflux disease has been suggested as a potential contributor to chronic rhinosinusitis, the specific endoscopic features indicative of nasopharyngeal pathology in CRS patients with GERD symptoms have not been clearly elucidated. Our aim is to identify specific endoscopic features of nasopharyngeal pathology in patients with CRS associated with GERD symptoms and to propose a method for assessing the influence of gastroesophageal reflux disease on the mucosal layer of the nose and nasopharynx. Materials and Methods: We conducted a cross-sectional observational study involving 521 adult patients presenting with symptoms suggestive of CRS. From this cohort, 95 patients with the highest scores on the Reflux Symptom Index (RSI) and Reflux Symptom Score-12 (RSS-12) questionnaires were selected as the main group. Endoscopic examinations were performed to assess the nasal and nasopharyngeal mucosa. Results: Our study revealed significant alterations in the nasopharyngeal mucosa of patients with CRS associated with GERD symptoms. Increased vascularity of the nasopharyngeal mucosa was observed in 91 patients (95.7%), while hypertrophy was noted in 83 patients (87.4%). Mucus was present in the nasopharynx of 77 patients (81.1%), exhibiting varying characteristics of color and consistency. Asymmetric hypertrophy of the oropharyngeal mucosa was noted in 62 patients (65.3%). Conclusions: We propose a method for assessing the influence of gastroesophageal reflux disease on the mucosal layer of the nose and nasopharynx, which may aid in diagnostic and management decisions. Further research is warranted to explore the potential impact of GERD symptoms on the course and severity of CRS exacerbations.

Verified
Journal Article
Open access
PDF file
KSKalamkas Sagandykova
Kalamkas Sagandykova
NPNataliya Papulova
Nataliya Papulova
GMGulmira Mukhamadiyeva
Gulmira Mukhamadiyeva
TATalapbek Azhenov
Talapbek Azhenov
Jerome R. LechienJerome R. Lechien
Jerome R. Lechien
Background: Chronic rhinosinusitis with or without nasal polyps (CRSwNPs/CRSsNPs) is an inflammatory disease that is becoming increasingly associated with laryngopharyngeal reflux disease (LPRD). Although symptom-based questionnaires, such as the Reflux Symptom Index (RSI) and Reflux Symptom Score (RSS), are widely used, there is a lack of objective endoscopic tools for assessing the nasopharyngeal and nasal manifestations of reflux. The Nasopharyngeal Reflux Endoscopic Score (NRES) is a novel endoscopic scoring system that was developed to address this issue. Objective: The objective of this study was to evaluate the diagnostic accuracy of the NRES in identifying LPRD in patients with CRS, compared with a clinical reference standard. Methods: A prospective diagnostic accuracy cohort study was conducted at two tertiary care centers in Astana, Kazakhstan, from September 2023 to February 2025. A total of 216 adults were enrolled and divided into three groups: CRS with suspected LPRD (n = 116), CRS without LPRD (n = 69), and healthy controls (n = 31). CRS was diagnosed according to the EPOS 2020 criteria. LPRD was defined using a composite reference standard comprising clinical assessment, RSS > 13, RSI, and selective 24 h pH monitoring and gastrointestinal endoscopy. All participants underwent nasopharyngeal and laryngeal endoscopy, with NRES, L-K, RFS, RSI, and RSS assessments at baseline and at 6 and 12 months. Receiver operating characteristic (ROC) analysis was used to evaluate the diagnostic performance, and Wilcoxon tests were used to analyze the changes in scores. Correlation and regression analyses were used to explore associations between scales and predictive factors. Results: At baseline, NRES scores were significantly higher in the CRS with LPRD group (mean: 11.59) than in the CRS without LPRD group (mean: 3.10) and the healthy control group (mean: 2.16) (p < 0.001). ROC analysis demonstrated excellent diagnostic accuracy, with an area under the curve (AUC) of 0.998 (95% confidence interval (CI): 0.994–1.000), a sensitivity of 98% (95% CI: 94–100%) and a specificity of 96% (95% CI: 91–99%) at an optimal cut-off point of 8.5. NRES scores showed strong correlations with RSI, RSS, and RFS scores (r > 0.76, p < 0.001). A longitudinal assessment revealed significant reductions in all scores after treatment with proton pump inhibitors and lifestyle modifications, with sustained improvement at 12 months. Regression analysis found no significant effect of age, gender, or GERD severity (LA classification) on NRES scores. Conclusions: The NRES is a highly sensitive and specific endoscopic tool for identifying nasopharyngeal changes associated with LPRD in CRS patients. It demonstrates strong correlations with established symptom-based and laryngoscopic reflux assessments and responds to anti-reflux therapy over time. The NRES may, therefore, be a valuable objective adjunct in the comprehensive evaluation and longitudinal monitoring of LPRD-associated CRS.

22 July 2026 in Medicina
Verified
Journal Article
Open access
PDF file
BABayan Aigozhina
Bayan Aigozhina
RTRais Tulebaeyv
Rais Tulebaeyv
TATalapbek Azhenov
Talapbek Azhenov
SZSerik Zhandayev
Serik Zhandayev
NPNataliya Papulova
Nataliya Papulova
KSKalamkas Sagandykova
Kalamkas Sagandykova
Background and Objectives: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a heterogeneous inflammatory disease of the nasal and paranasal sinus mucosa, associated with significant impairment in quality of life, frequent postoperative recurrence, and repeated need for systemic glucocorticosteroid therapy. Despite the availability of biologics targeting IL-4/IL-13, IL-5, and IgE, a subset of patients shows incomplete or insufficient clinical response. In this context, upstream targeting of epithelial alarmins, particularly thymic stromal lymphopoietin (TSLP), has emerged as a potential therapeutic strategy. To critically review current evidence on the role of TSLP in CRSwNP and to evaluate available data on the mechanism of action, clinical efficacy, and therapeutic potential of tezepelumab in severe and recurrent disease. Materials and Methods: A narrative review was conducted using PubMed, Scopus, and Web of Science. Studies published between 2016 and 2026 were included, comprising experimental research, phase II–III clinical trials, systematic reviews, and international guidelines. Results: TSLP functions as an epithelial alarmin that initiates and amplifies type 2 inflammation via dendritic cell activation, Th2 polarization, and activation of type 2 innate lymphoid cells (ILC2). Data suggests that tezepelumab, a monoclonal antibody targeting TSLP, may reduce inflammation and regulate the immune system. Evidence from asthma populations and relevant CRSwNP subgroups indicates potential improvements in nasal polyp score, congestion, olfactory function and quality of life. It is our understanding that the safety profile appears comparable to placebo, with no new safety concerns having been identified in long-term studies. Conclusions: Tezepelumab is a promising biologic that targets inflammation in CRSwNP. It may benefit severe, recurrent, treatment-resistant disease by modulating immune pathways. However, evidence is indirect and limited, and more trials are needed to define its efficacy, identify biomarkers, and clarify its role in treatment algorithms.

5 June 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
KSKalamkas Sagandykova
Kalamkas Sagandykova
NPNataliya Papulova
Nataliya Papulova
TATalapbek Azhenov
Talapbek Azhenov
ADAliya Darbekova
Aliya Darbekova
BABayan Aigozhina
Bayan Aigozhina
Jerome R. LechienJerome R. Lechien
Jerome R. Lechien
Chronic rhinosinusitis (CRS) is a complex inflammatory condition affecting the nasal and paranasal sinus mucosa. Gastroesophageal reflux disease (GERD) has been implicated as a potential exacerbating factor in CRS, but the specific endoscopic features of nasopharyngeal pathology in this context remain poorly understood. Background and Objectives: CRS is a multifactorial disease with various underlying etiologies, including inflammation, anatomical factors, and environmental triggers. While GERD has been suggested as a potential contributor to CRS, the specific endoscopic features indicative of nasopharyngeal pathology in CRS patients with GERD symptoms have not been clearly elucidated. Our aim is to identify specific endoscopic features of nasopharyngeal pathology in patients with CRS associated with GERD symptoms, and to propose a method for assessing the influence of GERD on the mucosal layer of the nose and nasopharynx. Materials and Methods: We conducted a cross-sectional observational study involving 521 adult patients presenting with symptoms suggestive of CRS. From this cohort, 95 patients with the highest scores on the Reflux Symptom Index (RSI) and Reflux Symptom Score-12 (RSS-12) questionnaires were selected as the main group. Endoscopic examinations were performed to assess the nasal and nasopharyngeal mucosa. Results: Our study revealed significant alterations in the nasopharyngeal mucosa of patients with CRS associated with GERD symptoms. Increased vascularity of the nasopharyngeal mucosa was observed in 91 patients (95.7%), while hypertrophy was noted in 83 patients (87.4%). Mucus was present in the nasopharynx of 77 patients (81.1%), exhibiting varying characteristics of color and consistency. Asymmetric hypertrophy of the oropharyngeal mucosa was noted in 62 patients (65.3%). Conclusions: We propose a method for assessing the influence of GERD on the mucosal layer of the nose and nasopharynx, which may aid in diagnostic and management decisions. Further research is warranted to explore the potential impact of GERD symptoms on the course and severity of CRS exacerbations.

28 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
KSKalamkas Sagandykova
Kalamkas Sagandykova
NPNataliya Papulova
Nataliya Papulova
GMGulmira Mukhamadiyeva
Gulmira Mukhamadiyeva
TATalapbek Azhenov
Talapbek Azhenov
Jerome R. LechienJerome R. Lechien
Jerome R. Lechien
Background: Chronic rhinosinusitis with or without nasal polyps (CRSwNP/CRSsNP) is a multifactorial inflammatory disease that is increasingly associated with laryn-gopharyngeal reflux disease (LPRD). While symptom-based questionnaires such as the Reflux Symptom Index (RSI) and Reflux Symptom Score (RSS) are commonly used, there is a lack of objective endoscopic tools to assess nasopharyngeal and nasal mani-festations of reflux. The Nasopharyngeal Reflux Endoscopic Score (NRES) was devel-oped to fill this gap. Objective: To evaluate the diagnostic utility of the NRES in patients with CRS and suspected LPRD and to compare its performance with existing clinical and endoscopic reflux assessment tools. Methods: A prospective longitudinal study was conducted with 216 adult participants divided into three groups: CRS with sus-pected LPRD (n = 116), CRS without LPRD (n = 69) and healthy controls (n = 31). The diagnosis of LPRD was suspected through gastrointestinal endoscopy, 24-hour pH monitoring, RSI and RSS. The diagnosis of CRS was made according to the EPOS 2020 criteria. All participants underwent nasopharyngeal and laryngeal endoscopy and were assessed at baseline, 6 months and 12 months using NRES, Lund-Kennedy (L-K), Reflux Finding Score (RFS), RSI and RSS. Receiver operating characteristic (ROC) analysis assessed diagnostic performance; Wilcoxon tests assessed score dynamics; correlation and regression analyses explored associations between scales and predic-tive factors. Results: At baseline, NRES scores were significantly higher in the CRS with LPRD group (mean: 11.59) compared to CRS without LPRD (mean: 3.10) and healthy controls (mean: 2.16) (p < 0.001). ROC analysis showed excellent diagnostic accuracy (AUC = 0.998) with 99% sensitivity and 96% specificity at a cut-off of 8.5. NRES showed strong correlations with RSI, RSS and RFS (r > 0.76, p < 0.001). Longitudinal assessment showed significant score reductions on all scales after treatment with proton pump inhibitors (PPIs) and lifestyle modifications, with sustained improvement at 12 months. Regression analysis showed no significant effect of age, gender or GERD severity (LA classification) on NRES scores. Conclusions: The NRES is a highly sensitive and specific endoscopic tool for identifying nasopharyngeal changes associated with LPRD in CRS patients. It shows strong correlations with both symptom-based and laryngoscopic re-flux assessment and responds to anti-reflux therapy over time. NRES may serve as a valuable objective adjunct in the comprehensive evaluation and longitudinal moni-toring of LPRD -associated CRS.

23 September 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BABayan Aigozhina
Bayan Aigozhina
RTRais Tulebaeyv
Rais Tulebaeyv
GMGulmira Mukhamadiyeva
Gulmira Mukhamadiyeva
TATalapbek Azhenov
Talapbek Azhenov
SSStanova Sayazhan
Stanova Sayazhan
KSKalamkas Sagandykova
Kalamkas Sagandykova
Background/Objectives: Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with substantial impairment of the health-related quality of life. The Sino-Nasal Outcome Test-22 (SNOT-22) is one of the most widely used patient-reported outcome measures in chronic rhinosinusitis. To our knowledge, no published psychometric evaluation of a Kazakh-language SNOT-22 has previously been reported. The aim of this study was to perform the cross-cultural adaptation and evaluate selected measurement properties of the Kazakh-language SNOT-22 in adults with CRSwNP. Methods: This prospective single-center study included 151 participants: 101 patients with CRSwNP (vitamin D supplementation group, n = 50; standard-treatment group, n = 51) and 50 healthy volunteers. Both patient groups underwent endoscopic sinus surgery and received topical glucocorticosteroids; adjunctive vitamin D was administered only in the vitamin D supplementation group according to the prespecified protocol. Cross-cultural adaptation was conducted according to ISPOR recommendations. The selected measurement properties examined were internal consistency, known-group validity, responsiveness, and exploratory associations with Lund–Kennedy endoscopic scores. Test–retest reliability and structural validity were not assessed. Results: Baseline SNOT-22 scores were substantially higher in patients with CRSwNP than in healthy volunteers (p < 0.001), although the interpretation of this known-group comparison is limited by significant age and sex imbalance between groups. In the combined target CRSwNP sample with complete item-level data (n = 99), Cronbach’s alpha was 0.921. Subgroup coefficients were 0.901 in the vitamin D supplementation group and 0.934 in the standard-treatment group, while the coefficient in healthy volunteers was 0.891. After one month, SNOT-22 scores decreased substantially in both patient groups (both p < 0.001), supporting the instrument’s ability to detect change over time. Baseline correlations with Lund–Kennedy scores were very weak and non-significant; stronger correlations were observed only after treatment. Conclusions: The Kazakh-language SNOT-22 showed promising initial measurement properties, including high internal consistency and the ability to distinguish patients from healthy volunteers and to detect longitudinal score changes. However, the psychometric evaluation remains incomplete because test–retest reliability, measurement error, and structural validity were not assessed, and evidence for convergent validity was limited. Further validation in larger, demographically balanced samples is required.